DE1189763B - Reagens zur Kontrolle der Gerinnungsfaehigkeit des Blutes waehrend einer Antikoagulantien-Therapie und Verfahren zur Herstellung des Reagens - Google Patents

Reagens zur Kontrolle der Gerinnungsfaehigkeit des Blutes waehrend einer Antikoagulantien-Therapie und Verfahren zur Herstellung des Reagens

Info

Publication number
DE1189763B
DE1189763B DEO6747A DEO0006747A DE1189763B DE 1189763 B DE1189763 B DE 1189763B DE O6747 A DEO6747 A DE O6747A DE O0006747 A DEO0006747 A DE O0006747A DE 1189763 B DE1189763 B DE 1189763B
Authority
DE
Germany
Prior art keywords
reagent
plasma
factor
thromboplastin
antihaemophilia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DEO6747A
Other languages
German (de)
English (en)
Inventor
Dr Med Paul Arnor Owren
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PAUL ARNOR OWREN DR MED
Original Assignee
PAUL ARNOR OWREN DR MED
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PAUL ARNOR OWREN DR MED filed Critical PAUL ARNOR OWREN DR MED
Publication of DE1189763B publication Critical patent/DE1189763B/de
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/96—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood or serum control standard
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2496/00—Reference solutions for assays of biological material
    • G01N2496/05—Reference solutions for assays of biological material containing blood cells or plasma

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DEO6747A 1958-05-16 1959-04-30 Reagens zur Kontrolle der Gerinnungsfaehigkeit des Blutes waehrend einer Antikoagulantien-Therapie und Verfahren zur Herstellung des Reagens Pending DE1189763B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NO12810458 1958-05-16

Publications (1)

Publication Number Publication Date
DE1189763B true DE1189763B (de) 1965-03-25

Family

ID=19908436

Family Applications (1)

Application Number Title Priority Date Filing Date
DEO6747A Pending DE1189763B (de) 1958-05-16 1959-04-30 Reagens zur Kontrolle der Gerinnungsfaehigkeit des Blutes waehrend einer Antikoagulantien-Therapie und Verfahren zur Herstellung des Reagens

Country Status (7)

Country Link
US (1) US3179567A (fr)
CH (1) CH408283A (fr)
DE (1) DE1189763B (fr)
ES (1) ES249137A1 (fr)
FR (1) FR1223856A (fr)
GB (1) GB917012A (fr)
NL (2) NL123584C (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0020895A1 (fr) * 1979-04-14 1981-01-07 BEHRINGWERKE Aktiengesellschaft Thromboplastine partielle
EP0083773A1 (fr) * 1981-12-21 1983-07-20 Roche Diagnostics GmbH Procédé pour la préparation d'une thromboplastine tissulaire composition

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3293134A (en) * 1961-09-08 1966-12-20 Warner Lambert Pharmaceutical Diagnostic reagent composition for determining blood coagulation factors and method of use
US3395210A (en) * 1964-02-07 1968-07-30 Warner Lambert Pharmaceutical Lyophilized diagnostic reagent for the determination of blood coagulation factors
US3486981A (en) * 1965-03-15 1969-12-30 Roy E Speck Substances relating to testing of blood-coagulation
US3228841A (en) * 1965-06-10 1966-01-11 Warner Lambert Pharmaceutical Diagnostic reagent composition for determining blood coagulation factors and method of use
US3880714A (en) * 1973-07-18 1975-04-29 Warner Lambert Co Diagnostic reagent
US3947378A (en) * 1974-12-23 1976-03-30 Warner-Lambert Company Adsorbed plasma
US4002739A (en) * 1975-02-18 1977-01-11 Warner-Lambert Company Soluble collagen
US4038147A (en) * 1976-06-15 1977-07-26 Becton, Dickinson And Company Method for detecting endotoxins
DE3407280A1 (de) * 1984-02-28 1985-09-19 Gödecke AG, 1000 Berlin Testsatz zur bestimmung der aktivierten partiellen thromboplastinzeit (ptt) mit erhoehter heparinempfindlichkeit
DE3413311A1 (de) * 1984-04-09 1985-10-17 Behringwerke Ag, 3550 Marburg Reagenz zur bestimmung der thromboplastinzeit
US4946775A (en) * 1985-09-05 1990-08-07 Yin E Thye Composition, kit and method for assaying heparin and a method for making the composition
US4851336A (en) * 1985-09-05 1989-07-25 Yin E Thye Composition, kit, and method for assaying heparinano a method for making the composition
US4948724A (en) * 1985-09-05 1990-08-14 Yin E Thye Composition, kit and method for assaying heparin and a method for making the composition
US4755461A (en) * 1986-04-17 1988-07-05 Bio/Data Corporation Tableted blood plasma microconcentrated thromboplastin coagulation reagent
AU744287B2 (en) * 1990-11-13 2002-02-21 Corvas International, Inc. Tissue factor based prothrombin time reagent
US5314695A (en) * 1990-11-13 1994-05-24 Corvas International, Inc. Tissue factor based prothrombin time reagent
US6203816B1 (en) * 1990-11-13 2001-03-20 Corvas International, Inc. Tissue factor based prothrombin time reagent
US6248353B1 (en) 1999-12-10 2001-06-19 Dade Behring Inc. Reconstitution of purified membrane proteins into preformed liposomes
US6596543B2 (en) 2001-03-22 2003-07-22 Dade Behring Inc. Use of liposomes of defined composition and size for the preparation of prothrombin time reagents
IS2809B (is) * 2011-03-08 2012-10-15 Haskoli Islands Blóðstorkumæling
JP7110360B2 (ja) 2017-10-09 2022-08-01 テルモ ビーシーティー バイオテクノロジーズ，エルエルシー 凍結乾燥方法
JP7471316B2 (ja) 2019-03-14 2024-04-19 テルモ ビーシーティー バイオテクノロジーズ，エルエルシー マルチパート凍結乾燥容器
CN112481355B (zh) * 2020-11-16 2023-05-30 武汉市长立生物技术有限责任公司 液体型凝血酶原时间测定试剂盒及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2687980A (en) * 1948-09-15 1954-08-31 Ernest W Blanchard Thromboplastin product and method for preparing same
US2847350A (en) * 1954-05-27 1958-08-12 Ortho Pharma Corp Preparation of highly active thromboplastin

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0020895A1 (fr) * 1979-04-14 1981-01-07 BEHRINGWERKE Aktiengesellschaft Thromboplastine partielle
EP0083773A1 (fr) * 1981-12-21 1983-07-20 Roche Diagnostics GmbH Procédé pour la préparation d'une thromboplastine tissulaire composition

Also Published As

Publication number Publication date
ES249137A1 (es) 1959-11-16
NL123584C (fr)
NL238873A (fr)
US3179567A (en) 1965-04-20
FR1223856A (fr) 1960-06-21
CH408283A (de) 1966-02-28
GB917012A (en) 1963-01-30

Similar Documents

Publication Publication Date Title
DE1189763B (de) Reagens zur Kontrolle der Gerinnungsfaehigkeit des Blutes waehrend einer Antikoagulantien-Therapie und Verfahren zur Herstellung des Reagens
DE69120674T2 (de) Koagulationsassays und reagenzien
DE69018910T2 (de) Verfahren zur Bestimmung des endogenen Thrombinpotentials von Plasma und Blut und Reagenziensatz zur Verwendung in besagtem Verfahren.
EP0174478B1 (fr) Procédé pour la précipitation sélective extracorporelle des lipoprotéines à basse densité dans du sérum ou du plasma sanguin
DE69033033T2 (de) Verbesserte kontrollverfahren für stabile blutkoagulation
EP0040799B1 (fr) Préparation stabilisée de thrombine
DE2734821A1 (de) Verfahren zur herstellung einer blutgerinnungsfoerdernden praeparation aus menschlichem blutplasma
DE3615558A1 (de) Verfahren zur herstellung eines faktor v-konzentrats
CH622101A5 (fr)
DE2602997C2 (de) Lyophilisierte Kollagenzubereitung und Verfahren zu ihrer Herstellung
DE2653537C3 (de) Verfahren und Mittel zur Bestimmung von Hydroperoxiden
EP3538898B1 (fr) Réactif pour le temps de prothrombine contenant un chélateur du fer
DE60032001T2 (de) Verfahren zur stabilisierung von thrombin
DE1598756A1 (de) Mittel zur Bestimmung von Harnstoff in Fluessigkeiten
CH625052A5 (fr)
EP0697463A1 (fr) Additifs pour essais diagnostiques de détermination de coagulabilité de sang, procédé de réduction d'influence d'héparine en essais diagnostiques et l'utilisation de sels métalliques pour ces buts
DE69804216T2 (de) Verhinderung der koagulation von blut-, blutplasma- bzw. synovialflüssigkeitsprodukten
DE3781279T2 (de) Verfahren zur behandlung von blut.
DE69119576T2 (de) Verfahren zur Abtrennung, Identifizierung und Quantifizierung von Isoenzymen und Isoformen der alkalischen Phosphatase
AT212979B (de) Reagens zur Kontrolle der Gerinnungsfähigkeit des Blutes und seine Herstellung
DE69030135T2 (de) Ein Reagenssystem zur Bestimmung von Lipase
EP0119990A2 (fr) Procédé de préparation de dérivés de plasma thérapeutiquement administrables, conditionnés dans des emballages prêts à l'emploi
DE2212285B2 (de) Verfahren zur Bestimmung der carcinogenen Aktivität und heptatoxischen Eigenschaften von Substanzen
EP0005243A2 (fr) Plasma de contrôle, sa préparation, son application au contrôle d'une thérapie orale à anticoagulants et trousse contenant ce plasma de contrôle
DE1617279A1 (de) Verfahren zur Herstellung pharmazeutischer Praeparate zur Verhinderung der Bildung von Blutgerinnseln